Calcium Gluconate Injection, Solution
Product Images NDC 0143-9184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Calcium Gluconate (NDC 0143-9184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton.jpg (Carton)

FDA Label Image

Structure.jpg (Structure)

FDA Label Image

Vial.jpg (Vial)

Vial.jpg (Vial)
Calcium Gluconate Injection, USP is a sterile solution used for intravenous administration. Each 50 mL single-dose vial contains 5,000 mg of calcium gluconate, equivalent to 100 mg per mL. The solution does not contain any preservatives and is free of aluminum, with no more than 400 mcg/L. The pH of the solution may have been adjusted using hydrochloric acid and/or sodium hydroxide. It has a concentration of 0.465 mEq/mL and 0.276 mOsmol/mL. The solution is stored at a controlled room temperature of 20° to 25°C (68° to 77°F) and should not be frozen. It should only be used if the solution is clear and the seal is intact. The container closure is latex-free. The usual dosage should be followed as specified in the package insert. Batch number, expiration date, and manufacturing license number are also provided. The product is manufactured by Nivagen Pharmaceuticals and distributed by Hikma Pharmaceuticals USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.